Regeneron Pharmaceuticals (REGN)

Retained Earnings

$37.62B

Quarterly · Period ending: · USD

REGN logo

REGN Retained Earnings

Latest reported$37.62B
REGN Quarterly Retained Earnings (-$7.00M → $37.62B)
High-resolution chart · PNG

REGN retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
37,621,000,000
36,423,800,000
35,797,100,000
35,045,800,000
33,680,200,000
32,384,400,000
31,672,900,000
30,755,200,000
29,414,600,000
27,982,300,000
27,260,300,000
26,100,700,000
25,092,900,000
24,124,500,000
23,306,700,000
22,109,600,000
20,793,900,000
19,941,800,000
18,968,300,000
16,739,300,000
15,107,100,000
12,008,200,000
10,893,000,000
9,743,800,000
8,901,700,000
8,004,400,000
7,379,800,000
6,587,800,000
5,918,200,000
5,725,100,000
5,254,300,000
4,433,904,000
3,839,179,000
3,287,767,000
2,946,733,000
2,773,214,000
2,384,897,000
1,997,153,000
1,748,222,000
1,495,107,000
1,230,303,000
1,018,436,000
852,700,000
697,706,000
487,308,000
292,665,000
255,382,000
145,206,000
65,486,000
-27,249,000
-92,692,000
-189,498,000
-330,804,000
-418,180,000
-517,054,000
-987,461,000
-1,178,929,000
-1,255,672,000
-1,267,323,000
-1,213,880,000
-1,151,515,000
-1,089,010,000
-1,045,563,000
-1,030,966,000
-997,091,000
-971,617,000
-941,095,000
-904,606,000
-903,591,000
-893,408,000
-875,927,000
-844,409,000
-823,294,000
-804,835,000
-793,217,000
-780,146,000
-744,308,000
-717,534,000
-687,617,000
-656,646,000
-629,236,000
-605,660,000
-585,280,000
-555,608,000
-520,956,000
-493,957,000
-489,834,000
-492,626,000
-481,550,000
-467,001,000
-531,533,000
-512,156,000
-482,921,000
-454,185,000
-424,075,000
-388,382,000
-355,566,000
-325,143,000
-299,698,000
-271,320,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.